Clinical study on effects of ulinastatin on patients with systemic inflammatory response syndrome

Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue

Volumn 17, Issue 4, 2005, Pages 228-230

  Shao, Yi ming ^a   Zhang, Liang qing ^a   Deng, Lie hua ^a   Yao, Hua guo ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; TRYPSIN INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GLYCOPROTEINS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRYPSIN INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 54049091881     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)